Chondroitin
Also known as: chondroitin sulfate, CS, chondroitin sulphate, CSU
Effective Dosage
No established dose from provided studies alone
What the Science Says
Chondroitin sulfate is a naturally occurring molecule found in cartilage and connective tissue. In the provided studies, it was tested as part of combination formulas (with collagen type II and glucosamine) and showed modest improvements in knee osteoarthritis symptoms like stiffness, quality of life, and sport/recreation scores over 12 weeks compared to placebo. Lab studies suggest it may protect cartilage cells by reducing inflammation and inhibiting a cell-death process called ferroptosis, though these findings are from animal and cell models, not confirmed in large human trials.
What It Doesn't Do
Won't rebuild cartilage — no human evidence from these studies shows structural repair. Not proven to work on its own; clinical benefits in provided studies came from multi-ingredient formulas. No evidence it helps IBS — one RCT found no significant benefit. Not a treatment for sepsis, hair loss, or liver injury despite lab research using it as a drug-delivery material.
Evidence-Based Benefits
Chondroitin sulfate has shown in vitro anti-inflammatory and chondroprotective effects, including reducing inflammatory cytokines (IL-1β, IL-6, TNF-α) in macrophages and upregulating cartilage matrix genes (aggrecan, type II collagen) in chondrocytes (PMID 41906404). In a rat OA model, CS attenuated cartilage degradation and inhibited chondrocyte ferroptosis via upregulation of HSPA8 and SLC7A11 (PMID 41712577). A small 12-week pilot RCT using a combination of collagen type II, glucosamine, and chondroitin sulfate showed improvements in knee OA symptoms and quality of life, though the primary endpoint was not met and the contribution of chondroitin alone cannot be isolated (PMID 40664872).
Weak EvidenceEffective at: No established dose from provided studies
Source: auto-research
Absorption & Bioavailability
Unknown from provided studies — no pharmacokinetic data reported in the abstracts provided.
Red Flags to Watch For
- Most clinical evidence in these studies comes from combination products (with glucosamine and collagen), making it impossible to isolate chondroitin's individual contribution
- The 12-week pilot study was small (52 participants) and did not meet its primary endpoint — larger confirmatory trials are still needed
- Lab and animal findings (anti-ferroptosis, anti-inflammatory) have not been confirmed in large human RCTs
- Widely used in over 1,000 registered supplement products despite limited standalone clinical evidence from the provided research
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06